Democrats’ Long-Sought Plan for Lowering Drug Costs Is at Hand

Top Stories World U.S. Business Technology Entertainment Sports Health

Democrats’ Long-Sought Plan for Lowering Drug Costs Is at Hand The New York Times
Democrats' drug pricing bill could lead to higher launch prices Axios
Opinion: Drug pricing reforms needed to lower out-of-pocket costs The Columbus Dispatch
AbbVie likely to see negotiated drug pricing under bill • HCSC plans Medicare Advantage expansion • Monkeypox declared an emergency Crain's Chicago Business
Democrats' backdoor crackdown on pharma "gaming" Axios
View Full Coverage on Google News

Empowering Medicare to negotiate prices directly with drug makers has been a Democratic goal for 30 years, one the pharmaceutical industry has fought ferociously.Empowering Medicare to negotiate prices directly with drug makers has been a Democratic goal for 30 years, one the pharmaceutical industry has fought ferociously.

www.nytimes.com

thehill.com

Please Wait... | Cloudflare

Industry advocates must explain how taking excess profits from pharma giants will affect startups, the real engine of pharma innovation.The solution to affordability is not to set prices below the cost of making new drugs. Instead, Americans must support as robust an innovation ecosystem as possible.

The outsized effect of ‘modest’ price controls on pharma innovation - STAT

twitter.com

The new prescription drugs bill unveiled last week would allow the federal government, the single largest purchaser of drugs in the U.S., to negotiate drug prices with pharmaceutical companies for the first time, bringing down costs for seniors and the government.The new prescription drugs bill unveiled last week would allow the federal government, the single largest purchaser of drugs in the U.S., to negotiate drug prices with pharmaceutical companies for the first time, bringing down costs for seniors and the government.

Prescription drug prices are high. Can the new Senate bill lower them?

Pharma companies like AbbVie, AstraZeneca, and Novo Nordisk will be hit harder by the drug-pricing bill than other drugmakers.Pharma companies like AbbVie, AstraZeneca, and Novo Nordisk will be hit harder by the drug-pricing bill than other drugmakers.

List of Drugs Affected by Medicare Negotiation in Inflation Reduction Act

Will your prescriptions cost less at the pharmacy? Not likely, says one expert.Will your prescriptions cost less at the pharmacy? Not likely, says one expert.

The Democrats' Deal Only Targets One Piece of Our Drug-Pricing Problem

Although the Biden Administration has repeatedly asserted that reducing cancer deaths and working towards ending cancer is a priority, Democrats’ dangerous price-setting scheme waves the white flag in the fight against this devastating disease. Americans need cancer treatments. Cancer assails nearly 40 percent of men and women at some point in their lifetime. In 2022 alone, there will be 1.9 […]

Democrats’ Price Control Scheme is a Surrender in the Fight Against Cancer - Ways and Means Republicans

No one denies that fewer new drugs will be a consequence of the Medicare drug pricing provisions the Democrats are trying to push through the U.S. Congress ahead of the midterm election campaign season. Less attention has been paid to the negative impact on drug-device combinations and new diagnostics that accompany innovative treatments.No one denies that fewer new drugs will be a consequence of the Medicare drug pricing provisions the Democrats are trying to push through the U.S. Congress ahead of the midterm election campaign season. Less attention has been paid to the negative impact on drug-device combinations and new diagnostics that accompany innovative treatments.

Impact of U.S. price controls could be far-reaching | BioWorld

The debate over drug pricing tends to heat up during election season. With the mid-terms in November, we’re going through the cycle once again, sparked by provisions in the Inflation Reduction Act.The debate over drug pricing tends to heat up during election season. With the mid-terms in November, we’re going through the cycle once again, sparked by provisions in the Inflation Reduction Act.

Drug Pricing Debates Heat Up Just in Time for Election Season | BioSpace

New research shows that drug price controls will actually increase total U.S. spending on healthcare by $50 billion over the next two decades.New research shows that drug price controls will actually increase total U.S. spending on healthcare by $50 billion over the next two decades.

AFP on Inclusion of Drug Price Controls and Wasteful Health Subsidies in Partisan Spending Bill - Americans for Prosperity

The Manchin-Schumer deal points to a different future.The Manchin-Schumer deal points to a different future.

The significance of the Inflation Reduction Act - The Boston Globe

Value-based price for access (VBPA) may increase access of specialty drugs for patients.Value-based price for access (VBPA) may increase access of specialty drugs for patients.

Payers Believe Lowering Drug Prices While Improving Patient Access Is Possible—but There’s a Catch

Big pharma executives are worried that one part of the Inflation Reduction Act will reduce their companies' profits.Big pharma executives are worried that one part of the Inflation Reduction Act will reduce their companies' profits.

Medicare Drug Pricing Changes Could Be Coming: Time to Ditch Pharma Stocks? | The Motley Fool

Executives at AbbVie, J&J, and Merck say the suggested changes in their current form would be 'chilling' or 'detrimental' to the development of new therapies.Executives at AbbVie, J&J, and Merck say the suggested changes in their current form would be 'chilling' or 'detrimental' to the development of new therapies.

Pharmaceutical CEOs use earnings calls to criticize drug-pricing proposal - MarketWatch

Democrats say they have reached an agreement on the Inflation Reduction Act, which includes measures aimed at lowering prescription-drug prices. Senate lawmakers could begin considering its passage this week. Donna Christensen, board member of Consumers for Quality Care and former Congressional Representative from the US Virgin Islands, said if passed into law, the changes would primarily affect Americans relying on Medicare. ...Democrats say they have reached an agreement on the Inflation Reduction Act, which includes measures aimed at lowering prescription-drug prices. Senate lawmakers could begin considering its passage this week. Donna Christensen, board member of Consumers for Quality Care and former Congressional Representative from the US Virgin Islands, said if passed into law, the changes would primarily affect Americans relying on Medicare. ...

Lawmakers Mull Drug Pricing Reforms as Costs Become Top Issue for Voters / Public News Service

The cost of prescription drugs have been a political issue for years. If Congress passes the Reduce Inflation Act, a provision would allow Medicare, for the first time, to negotiate drug prices.The cost of prescription drugs have been a political issue for years. If Congress passes the Reduce Inflation Act, a provision would allow Medicare, for the first time, to negotiate drug prices.

Democrats may make some progress toward lowering high drug prices | Wyoming Public Media

Please Wait... | Cloudflare

As a pharmacist, I know the best way to keep people healthy is to prevent disease or to identify sickness in the early stages when treatment can be most effective.As a pharmacist, I know the best way to keep people healthy is to prevent disease or to identify sickness in the early stages when treatment can be most effective.

Letter to the editor: Congress must make prescriptions affordable | Letters | missoulian.com

bloximages.chicago2.vip.townnews.com

Bloomberg - Are you a robot?

Drugmakers stand to lose the most product revenue from proposed legislation that would allow Medicare to negotiate prices.Lilly, AZ, AbbVie and J&J are among the drugmakers who stand to lose the most product revenue from proposed legislation that would allow Medicare to negotiate prices.

Analysts: Medicare price controls could blunt revenues of branded drugs

Drug Pricing Initiatives: The Senate is expected to vote on a revised version of H.R. 5376 (the Build Back Better Act, or BBBA), now styled as the Inflation Reduction Act of 2022 (IRA)....Drug Pricing Initiatives: The Senate is expected to vote on a revised version of H.R. 5376 (the Build Back Better Act, or BBBA), now styled as the Inflation Reduction Act of 2022 (IRA). The House...

Health Care & Life Sciences: Drug Pricing Digest - August 2022 | Latham & Watkins LLP - JDSupra

The current U.S. Senate budget reconciliation package is hyper-focused on bringing down drug prices. Unfortunately, the legislation is short-sighted, and ignores a key remedy that would help lower out-of-pocket costs for medicines: reforms for pharmacy benefit managers.The current U.S. Senate budget reconciliation package is hyper-focused on bringing down drug prices. Unfortunately, the legislation is short-sighted, and ignores a key remedy that would help lower out-of-pocket costs for medicines: reforms for pharmacy benefit managers.

Oncology patients at serious risk with Congress’ drug pricing plan - Ohio Capital Journal

Crain's Health Pulse is your source for actionable, exclusive and inside news on the health care industry.Crain's Health Pulse is your source for actionable, exclusive and inside news on the health care industry.

AbbVie likely to see negotiated drug pricing under bill • HCSC plans Medicare Advantage expansion | Crain's Chicago Business

The drug industry warns the bill will stifle innovation post-approval.The drug industry warns the bill will stifle innovation post-approval.

Democrats' backdoor crackdown on pharma "gaming"

US drug pricing bill could reduce manufacturer revenue by over $450 billion

US drug pricing bill could reduce manufacturer revenue by over $450 bi

HEALTH CARE BRIEFING: Democrats Face Messaging War on Drug Bill | Bloomberg Government

KHN chief Washington correspondent Julie Rovner discusses the Senate Democrats’ plans to let Medicare negotiate some drug prices, cap out-of-pocket drug costs for seniors, and fund enhanced subsides for ACA marketplace health plans.KHN chief Washington correspondent Julie Rovner discusses the Senate Democrats’ plans to let Medicare negotiate some drug prices, cap out-of-pocket drug costs for seniors, and fund enhanced subside…

Watch: Explaining the Nitty-Gritty of Medicare Drug Price Negotiations — And Patients’ Potential Savings | Kaiser Health News

Watch: Explaining the Nitty-Gritty of Medicare Drug Price Negotiations — And Patients’ Potential Savings – Kaiser Health News

Democrats are proposing price controls on medicine in their latest iteration of reconciliation. Price controls create shortages and discourage companies from entering the market. In healthcare, shortages and a lack of innovation costs lives. Lawmakers must reject this proposal. Specifically, the bill would give the Health and Human Services Secretary the authority to “negotiate” the […]

Drug Price Controls Will Cost Lives, Not Save Them - Americans for Tax Reform

The U.S. Senate is on the verge of passing one of the biggest healthcare and energy bills in a generation after over a year of failed talks and negotiations. The bill known as the Inflation Reduction Act of 2022 is designed to reduce costs for families and consumers. If it passes, it will allow Medicare to negotiate the prices of certain medications, and it would cap out-of-pocket costs at $2,000 for those enrolled in Medicare drug plans. It would also extend expiring enhanced subsidies for Affordable Care Act coverage for three years. The bill would also inject $369 billion into […]

What’s in the New Healthcare Bill Working Its Way Through Congress? - Scrubs | The Leading Lifestyle Magazine for the Healthcare Community

scrubsmag.com

What’s in the New Healthcare Bill Working Its Way Through Congress? - Scrubs | The Leading Lifestyle Magazine for the Healthcare Community

Price controls in the Inflation Reduction Act will devastate future drug development and raise costs.Price controls in the Inflation Reduction Act will devastate future drug development and raise costs.

The Inflation Reduction Act Will Raise Drug Costs and Reduce Cures | Citizens Against Government Waste

A group of biotech investors and doctors are warning that the Senate's drug-pricing proposal, aimed at lowering skyrocketing prices, would "strike a huge blow" to patient access and halt research on new treatments for Alzheimer's disease, heart disease and cancer.A group of biotech investors and doctors are warning that the Senate’s drug-pricing proposal, aimed at lowering skyrocketing prices, would “strike a huge blow” to patient access and halt research on n

Biotech investors sound alarm on Senate drug-pricing bill - Washington Times

The Inflation Reduction Act of 2022, a sweeping budget measure that now looks likely to pass in the US, contains measures to greatly reduce US prescription drug prices.The Inflation Reduction Act of 2022, a sweeping budget measure that now looks likely to pass in the US, contains measures to greatly reduce US prescription drug prices.

US Democrats' blockbuster budget bill could spell big changes for drug prices -

Democratic Sens. Chuck Schumer and Joe Manchin call their legislation the Inflation Reduction Act. Don't let the title fool you. The bill cripples the ability of drug companies to develop new cures. It should be called the Lifespan Reduction Act.Democratic Sens. Chuck Schumer and Joe Manchin call their legislation the Inflation Reduction Act. Don’t let the title fool you. The bill cripples the ability of drug companies to develop new…

McCaughey: Democrats pushing lifespan reduction bill on Americans

sports.yahoo.com

Nathan Ramsbacher writes, I see patients every day who need prescription medicines to preserve health or treat early illness in order to prevent acute problems later on but unfortunately all too many patients can’t afford them.Nathan Ramsbacher writes, I see patients every day who need prescription medicines to preserve health or treat early illness in order to prevent acute problems later on but unfortunately all too many patients can’t afford them.

Viewpoint: Monopoly drug pricing by Big Pharma doesn’t help patients

Across the pond, Brits are demanding their next prime minister do something to reduce the U. K.

The Democrats' Lifespan Reduction Act, by Betsy McCaughey | Creators Syndicate

Your View: President Biden's goal to eliminate cancer is laudable but the legislation he is supporting will make it less profitable for drug companies to invest in new medicines making it more difficult to fight the disease, the author contends.Your View: President Biden's goal to eliminate cancer is laudable but the legislation he is supporting will make it less profitable for drug companies to invest in new medicines making it more difficult to fight the disease, the author contends.

Your View: If Congress imposes price controls on drugs, patients will suffer – The Morning Call

Democrats want to go into their August recess telling their constituents they’re lowering what they pay for medicines — but many of their promised changes won’t be felt for years, and only by a fraction of the nation.Democrats want to go into their August recess telling their constituents they’re lowering what they pay for medicines — but many of their promised changes won’t be felt for years, and only by a fraction of the nation.

news.bloomberglaw.com

Senate Democrats have won a key vote from Joe Manchin on the Inflation Reduction Act.

QUESTION OF THE DAY: Should Congress act to lower prescription drug prices - ABC17NEWS

WASHINGTON — For many years, as prescription drug prices have soared, Democrats have battled with the pharmaceutical trade in pursuit of an elusive aim: laws

Democrats’ Long-Sought Plan for Lowering Drug Costs Is at Hand | Global Online Money